Skip to main content
. 2020 Aug 31;7:570. doi: 10.3389/fvets.2020.00570

Figure 3.

Figure 3

(A) Lameness improvement during the first 30 days. Note all doses of MSCs improved lameness. The response to MSC therapy was varied among different patients. Overall, there was a trend that higher doses of MSCs resulted in more improvement. No improvement in average lameness score was seen in the Placebo group. (B) Lameness improvement after 90 days showed similar results as after 30 days. All doses of MSCs improved lameness and the response to MSC therapy varied among different patients in all groups. Overall, there was a trend that higher doses of MSCs resulted in more improvement. No improvement in average lameness scores was seen in the Placebo group. (C) Lameness Improvement due to MSC administration. The graph represents cumulative data collected at days 30 and 90 regarding lameness improvement in Placebo group as compared to all MSC groups. The graph clearly shows a significant improvement in lameness score in the MSC groups as compared to the Placebo group (P < 0.001).